Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.

Clicks: 233
ID: 59213
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
A recent publication in Clinical Pharmacology and Therapeutics (CPT) by van der Wouden and colleagues on the preemptive pharmacogenomic PGx Passport, intended to optimize drug prescribing, caught my attention. I believe that the overall narrative of the paper is disproportional to the supporting evidence. The Editors of CPT did not find that my comment and reflections on this paper could be prioritized. I hope that BCPT will endorse a discussion of how we, as a research community, frame and disseminate our findings.
Reference Key
damkier2019obviouslybasic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Damkier, Per;
Journal basic & clinical pharmacology & toxicology
Year 2019
DOI
10.1111/bcpt.13335
URL
Keywords
precision medicine clinical pharmacogenomics dissemination of research pharmacogenetics/pharmacogenomics rational pharmacotherapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.